Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-12-07

Clinical Trial Update: The Effects of TMZ on Diabetic Nephropathy [Phase 2]

View source ↗

Summary

Phase 2 trial updating the effects of temozolomide (TMZ) on diabetic nephropathy is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Temozolomide (Temozolomide)

Snippet

Sponsor: Tongji Hospital | Conditions: Diabetic Nephropathies | Phase 2 | Status: UNKNOWN